[go: up one dir, main page]

IT1319275B1 - Uso del baclofen nel trattamento dell'astinenza da etanolo. - Google Patents

Uso del baclofen nel trattamento dell'astinenza da etanolo.

Info

Publication number
IT1319275B1
IT1319275B1 IT1999MI002107A ITMI992107A IT1319275B1 IT 1319275 B1 IT1319275 B1 IT 1319275B1 IT 1999MI002107 A IT1999MI002107 A IT 1999MI002107A IT MI992107 A ITMI992107 A IT MI992107A IT 1319275 B1 IT1319275 B1 IT 1319275B1
Authority
IT
Italy
Prior art keywords
baclofen
treatment
abstinence
ethanol
ethanol abstinence
Prior art date
Application number
IT1999MI002107A
Other languages
English (en)
Inventor
Gian Luigi Gessa
Giancarlo Colombo
Giovanni Addolorato
Original Assignee
Neuroscienze S C A R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuroscienze S C A R L filed Critical Neuroscienze S C A R L
Publication of ITMI992107A0 publication Critical patent/ITMI992107A0/it
Priority to IT1999MI002107A priority Critical patent/IT1319275B1/it
Priority to AU79146/00A priority patent/AU7914600A/en
Priority to AT00969423T priority patent/ATE300295T1/de
Priority to PL354083A priority patent/PL200525B1/pl
Priority to DK00969423T priority patent/DK1217999T3/da
Priority to ES00969423T priority patent/ES2246900T3/es
Priority to PCT/EP2000/009750 priority patent/WO2001026638A2/en
Priority to DE60021590T priority patent/DE60021590T2/de
Priority to EP00969423A priority patent/EP1217999B1/en
Priority to CA002386817A priority patent/CA2386817C/en
Priority to HK02109321.9A priority patent/HK1048062A1/zh
Publication of ITMI992107A1 publication Critical patent/ITMI992107A1/it
Application granted granted Critical
Publication of IT1319275B1 publication Critical patent/IT1319275B1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IT1999MI002107A 1999-10-08 1999-10-08 Uso del baclofen nel trattamento dell'astinenza da etanolo. IT1319275B1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT1999MI002107A IT1319275B1 (it) 1999-10-08 1999-10-08 Uso del baclofen nel trattamento dell'astinenza da etanolo.
PCT/EP2000/009750 WO2001026638A2 (en) 1999-10-08 2000-10-05 The use of baclofen in the treatment of alcoholism
AT00969423T ATE300295T1 (de) 1999-10-08 2000-10-05 Verwendung von baclofen zur behandlung von alkoholismus
PL354083A PL200525B1 (pl) 1999-10-08 2000-10-05 Zastosowanie baklofenu do wytwarzania leku
DK00969423T DK1217999T3 (da) 1999-10-08 2000-10-05 Anvendelse af baclofen til behandling af alkoholisme
ES00969423T ES2246900T3 (es) 1999-10-08 2000-10-05 Uso de baclofeno en el tratamiento del alcoholismo.
AU79146/00A AU7914600A (en) 1999-10-08 2000-10-05 The use of baclofen in the treatment of alcohol withdrawal syndrome and to promote alcohol abstinence in alcoholics
DE60021590T DE60021590T2 (de) 1999-10-08 2000-10-05 Verwendung von baclofen zur behandlung von alkoholismus
EP00969423A EP1217999B1 (en) 1999-10-08 2000-10-05 The use of baclofen in the treatment of alcoholism
CA002386817A CA2386817C (en) 1999-10-08 2000-10-05 The use of baclofen in the treatment of alcoholism
HK02109321.9A HK1048062A1 (zh) 1999-10-08 2000-10-05 巴氯酚(baclofen)在酒精中毒治療中的應用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI002107A IT1319275B1 (it) 1999-10-08 1999-10-08 Uso del baclofen nel trattamento dell'astinenza da etanolo.

Publications (3)

Publication Number Publication Date
ITMI992107A0 ITMI992107A0 (it) 1999-10-08
ITMI992107A1 ITMI992107A1 (it) 2001-04-08
IT1319275B1 true IT1319275B1 (it) 2003-09-26

Family

ID=11383744

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI002107A IT1319275B1 (it) 1999-10-08 1999-10-08 Uso del baclofen nel trattamento dell'astinenza da etanolo.

Country Status (11)

Country Link
EP (1) EP1217999B1 (it)
AT (1) ATE300295T1 (it)
AU (1) AU7914600A (it)
CA (1) CA2386817C (it)
DE (1) DE60021590T2 (it)
DK (1) DK1217999T3 (it)
ES (1) ES2246900T3 (it)
HK (1) HK1048062A1 (it)
IT (1) IT1319275B1 (it)
PL (1) PL200525B1 (it)
WO (1) WO2001026638A2 (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
EP2354120A1 (en) 2003-08-20 2011-08-10 XenoPort, Inc. Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
MXPA06001876A (es) 2003-08-20 2006-05-17 Xenoport Inc Prodrogas de aciloxialquil carbamato, metodos de sintesis y uso.
WO2006050471A2 (en) 2004-11-03 2006-05-11 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
WO2006050472A2 (en) 2004-11-03 2006-05-11 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous and -phosphinic acids
US7585996B2 (en) 2006-09-15 2009-09-08 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
TWI380812B (zh) 2008-01-25 2013-01-01 Xenoport Inc (3s)-胺甲基-5-甲基己酸前藥之晶形及使用方法
EP2250148B1 (en) 2008-01-25 2016-08-17 XenoPort, Inc. Crystalline form of calcium-salts of (3s)-aminomethyl-5-methyl-hexanoic acids and methods of use
WO2009094577A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
US7989641B2 (en) 2008-08-07 2011-08-02 Xenoport, Inc. Methods of synthesizing N-hydroxysuccinimidyl carbonates
US8299291B2 (en) 2008-08-07 2012-10-30 Xenoport, Inc. Methods of synthesizing 1-(acyloxy)-alkyl carbamate prodrugs
JP2012519212A (ja) 2009-03-03 2012-08-23 ゼノポート,インコーポレイティド R−バクロフェンプロドラッグの持効性放出経口投与形
EP2419401A2 (en) 2009-04-17 2012-02-22 XenoPort, Inc. GAMMA-AMINO-BUTYRIC ACID DERIVATIVES AS GABAb RECEPTOR LIGANDS
DE102010011069A1 (de) 2010-03-11 2011-09-15 Susanne Haamann Verfahren zur gezielten pharmakologischen und co-psychotherapeutischen Behandlung der Alkoholabhängigkeit mit Baclofen und Nalmefen
US8580850B2 (en) 2011-08-11 2013-11-12 Xenoport, Inc. Anhydrous and hemihydrate crystalline forms of an (R)-baclofen prodrug, methods of synthesis and methods of use
EP3244884A4 (en) * 2015-01-15 2018-07-25 Allaysis, LLC Intravenous baclofen formulations and treatment methods

Also Published As

Publication number Publication date
ITMI992107A0 (it) 1999-10-08
DE60021590T2 (de) 2006-05-24
CA2386817A1 (en) 2001-04-19
WO2001026638A2 (en) 2001-04-19
ATE300295T1 (de) 2005-08-15
EP1217999A2 (en) 2002-07-03
CA2386817C (en) 2009-05-12
EP1217999B1 (en) 2005-07-27
PL200525B1 (pl) 2009-01-30
ITMI992107A1 (it) 2001-04-08
PL354083A1 (en) 2003-12-29
DE60021590D1 (de) 2005-09-01
WO2001026638A3 (en) 2002-02-28
AU7914600A (en) 2001-04-23
DK1217999T3 (da) 2005-11-28
ES2246900T3 (es) 2006-03-01
HK1048062A1 (zh) 2003-03-21

Similar Documents

Publication Publication Date Title
IT1319275B1 (it) Uso del baclofen nel trattamento dell'astinenza da etanolo.
MX9700534A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para tratar las enfermedades de prostata, endometriosis y obesidad.
NO20024309D0 (no) Intradermal penetreringsmidler for topikal lokal anestetisk administrering
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
CL2004000675A1 (es) Uso de una combinacion de androgeno de origen biogenico o sintetico y un estrogeno de origen biogenico o sintetico para preparar un medicamento util en el tratamiento del hipogonadismo y enfermedades hipofisis o glandula pituitaria en hombres, para e
ATE333896T1 (de) Vaskularisierungsinhibitoren
EE03975B1 (et) Keratinotsüüdi kasvufaktori analoogid
KR970702733A (ko) 활성물질의 방출 조절용 콜라겐 제제(collagen preparation the controlled release of active substances)
ES2167401T3 (es) Uso de ascorbil-gamma-linolenato o un ascorbil-dihomo-gamma-linolenato para el tratamiento de asma, cancer, enfermedades cardiovasculares y anti-inflamatorias.
SE9603725D0 (sv) New teatment
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
ES2132556T3 (es) Nuevo derivado de benzo-tiadiazina, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
BG101401A (bg) Състави за орално приложение с удължено освобождаване на цисаприд
AR031601A1 (es) Derivados de 4-pirimidinamina, composiciones farmaceuticas y metodos relacionados
CY1104971T1 (el) Παρασκευασμα αποϊνιδοτιδιου και g-csf και η χρηση του για να κινητοποιει αιμοποιητικους προγονους
DK0391185T3 (da) 1,8-Naphthyridiner
NO974708L (no) Levobupivacain og dets anvendelse som anestetikum i gravide kvinner
MY136281A (en) Cyclodextrin-containing absorbent article
ES2183890T3 (es) Uso del factor de crecimiento de hepatocitos para in estimular la proliferacion y diferenciacion de celulas hematopoyeticas.
CY1107227T1 (el) Θεραπεια αυτοανοσων νοσων με εκχυλισμα αμερικανικου γκινσενγκ
BR0012006A (pt) Método para evitar inflamações, doenças autoimunes e crescimento de tumor, e, uso de substâncias que suprimem a ativação mediada por ltbr
FI920268A0 (fi) Tricykliskt pyridonderivat.
ES2173180T3 (es) Derivados del mercaptoacetilamida hipocolesterolemicos, antiateroescleroticos e hipotrigliceridemicos.
TR200001075T2 (tr) Tiamfenikol ve diklofenak içeren bileşimler.
IT1276040B1 (it) Uso della benzidamina nel trattamento di stati patologici causati dal tnf